Voya Investment Management LLC Makes New Investment in Ralliant Corporation $RAL

Voya Investment Management LLC bought a new position in Ralliant Corporation (NYSE:RAL) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 13,552 shares of the company’s stock, valued at approximately $593,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. ST Germain D J Co. Inc. acquired a new stake in Ralliant in the second quarter valued at about $27,000. Manchester Capital Management LLC purchased a new position in shares of Ralliant during the 2nd quarter worth approximately $29,000. Evermay Wealth Management LLC acquired a new stake in shares of Ralliant in the 2nd quarter valued at approximately $32,000. SouthState Corp acquired a new stake in shares of Ralliant in the 2nd quarter valued at approximately $35,000. Finally, EverSource Wealth Advisors LLC purchased a new stake in shares of Ralliant in the second quarter valued at approximately $39,000.

Ralliant Trading Down 0.4%

Shares of NYSE RAL opened at $50.99 on Friday. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.03 and a current ratio of 1.49. The company has a 50-day simple moving average of $48.32. Ralliant Corporation has a 52 week low of $40.70 and a 52 week high of $55.08. The firm has a market cap of $5.75 billion and a PE ratio of 40.15.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.02. The business had revenue of $529.10 million during the quarter, compared to analysts’ expectations of $519.14 million. Ralliant has set its Q4 2025 guidance at 0.620-0.680 EPS.

Ralliant Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Monday, December 8th were issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date was Monday, December 8th. Ralliant’s dividend payout ratio is 15.75%.

Analysts Set New Price Targets

RAL has been the subject of several research analyst reports. Citigroup upgraded Ralliant from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $53.00 to $61.00 in a research report on Monday, December 8th. Royal Bank Of Canada increased their price target on shares of Ralliant from $45.00 to $52.00 and gave the company a “sector perform” rating in a report on Friday, November 7th. Truist Financial began coverage on shares of Ralliant in a research note on Friday, December 12th. They issued a “buy” rating and a $62.00 price objective for the company. Oppenheimer upped their target price on shares of Ralliant from $55.00 to $60.00 and gave the stock an “outperform” rating in a research report on Monday, December 15th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Ralliant in a report on Monday. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $57.89.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.